References
- Noia G, Pellegrino M, Masini L, et al. Fetal cystic hygroma: the importance of natural history. Eur J Obstet Gynecol Reprod Biol 2013;170:407–13
- Scholl J, Durfee SM, Russell MA, et al. First-trimester cystic hygroma: relationship of nuchal translucency thickness and outcomes. Obstet Gynecol 2012;120:551–9
- Rosati P, Guariglia L. Prognostic value of ultrasound findings of fetal cystic hygroma detected in early pregnancy by transvaginal sonography. Ultrasound Obstet Gynecol 2000;16:245–50
- Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype–phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002;70:1555–63
- Malone FD, Ball RH, Nyberg DA, et al. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol 2005;106:288–94
- Bronshtein M, Zimmer EZ, Blazer S. A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy. Am J Obstet Gynecol 2003;188:1016–20
- Bilardo CM, Müller MA, Pajkrt E, et al. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 2007;30:11–18
- Bilardo CM, Timmerman E, Pajkrt E, van Maarle M, et al. Increased nuchal translucency in euploid fetuses – what should we be telling the parents? Prenat Diagn 2010;30:93–102
- Kamble V, Bhatia T, Patil S. Cystic hygroma with hydrops fetalis: a rare case report. Int J Reprod Contracept Obstet Gynecol 2014;3:847–50
- Hiippala A, Eronen M, Taipale P, et al. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Ultrasound Obstet Gynecol 2001;18:18–22
- Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet 2013;14:355–69
- Roberts AE, Allanson JE, Tartaglia M, Gelb BD, et al. Noonan syndrome. Lancet 2013;381:333–42
- Tartaglia M, Gelb BD. Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet 2005;48:81–96
- Wakabayashi Y, Yamazaki K, Narumi Y, et al. Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His. Am J Med Genet A 2011;155A:2529–33
- Digilio MC, Sarkozy A, Pacileo G, et al. PTPN11 gene mutations: linking the Gln510Glu mutation to the “LEOPARD syndrome phenotype”. Eur J Pediatr 2006;165:803–5
- Faienza MF, Giordani L, Ferraris M, et al. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link? Pediatr Cardiol 2009;30:1012–5
- Lehmann LH, Schaeufele T, Buss SJ, et al. IMAGE CARDIO MED. A patient with LEOPARD syndrome and PTPN11 mutation. Circulation 2009;119:1328–9
- Takahashi K, Kogaki S, Kurotobi S, et al. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. Eur J Pediatr 2005;164:497–500
- Croonen EA, Nillesen WM, Stuurman KE, et al. Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings. Eur J Hum Genet 2013;21:936–42